Therefore, it is possible that inhibition of HDAC6 and HDAC3 all contributed to the SAHA induced survivin acetylation, nuclear translocation, and the subsequent protein degradation in breast cancer cells. This evidence concerns the gene HDAC3 and breast carcinoma.